Literature DB >> 9810317

Adjuvant radiotherapy after radical hysterectomy of the cervical cancer. Prognostic factors and complications.

M Chatani1, T Nose, N Masaki, T Inoue.   

Abstract

AIM: To investigate prognostic factors and complications after radical hysterectomy followed by postoperative radiotherapy for carcinoma of the uterine cervix. PATIENTS AND METHODS: One hundred twenty-eight patients with T1b-2b carcinoma of the uterine cervix following radical hysterectomy with bilateral pelvic lymphadenectomy and postoperative radiation therapy were reviewed. Pathologic and treatment variables were assessed by multivariate analysis for local recurrence, distant metastases and cause specific survival.
RESULTS: The number of positive nodes (PN) in the pelvis was the strongest predictor of pelvic recurrence and distant metastases. These 2 failure patterns independently affect the cause specific survival. The 5-year cumulative local and distant failure were PN(0): 2% and 12%, PN(1-2): 23% and 25%, PN(2 <): 32% and 57%, respectively (p = 0.0029 and p = 0.0051). The 5-year cause specific survival rates were PN(0): 90%, PN(1-2): 59% and PN(2 <): 42% (p = 0.0001). The most common complication was lymphedema of the foot experienced by one-half of the patients (5-year: 42%, 10-year: 49%).
CONCLUSION: These results suggest that patients with pathologic T1b-T2b cervix cancer with pelvic lymph node metastases are at high risk of recurrence or metastases after radical hysterectomy with pelvic lymphadenectomy and postoperative irradiation.

Entities:  

Mesh:

Year:  1998        PMID: 9810317     DOI: 10.1007/bf03038982

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  16 in total

Review 1.  Combined radiotherapy and surgery: local control and complications in early carcinoma of the uterine cervix--the Villejuif experience, 1975-1984.

Authors:  A L Gerbaulet; I H Kunkler; G R Kerr; C Haie; G Michel; M Prade; C Lhomme; M Masselot; M Albano; A Dutreix
Journal:  Radiother Oncol       Date:  1992-02       Impact factor: 6.280

2.  Influence of histological features and treatment on the prognosis of patients with cervical cancer metastatic to pelvic lymph nodes.

Authors:  M L Berman; S Bergen; H Salazar
Journal:  Gynecol Oncol       Date:  1990-11       Impact factor: 5.482

3.  Treatment of primary invasive cervical cancer. Considerations on 997 consecutive cases.

Authors:  U A Bianchi; E Sartori; S Pecorelli; A Cavagnini; G Baroncelli; B La Face; A Gastaldi
Journal:  Eur J Gynaecol Oncol       Date:  1988       Impact factor: 0.196

4.  Potential pitfalls in the use of p-values and in interpretation of significance levels.

Authors:  H P Beck-Bornholdt; H H Dubben
Journal:  Radiother Oncol       Date:  1994-11       Impact factor: 6.280

5.  Is pelvic radiation beneficial in the postoperative management of stage Ib squamous cell carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy? A report from the Presidential Panel at the 1979 Annual Meeting of the Society of Gynecologic Oncologists.

Authors: 
Journal:  Gynecol Oncol       Date:  1980-08       Impact factor: 5.482

6.  Node-positive cervical cancer: impact of pelvic irradiation and patterns of failure.

Authors:  R G Stock; A S Chen; J C Flickinger; S Kalnicki; J Seski
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-01-01       Impact factor: 7.038

7.  Prophylactic irradiation of para-aortic lymph nodes in carcinoma of the uterine cervix. A prospective randomized study.

Authors:  M Chatani; Y Matayoshi; N Masaki; Y Narumi; T Teshima; T Inoue
Journal:  Strahlenther Onkol       Date:  1995-11       Impact factor: 3.621

8.  Stage IB carcinoma of the cervix, the Norwegian Radium Hospital, 1968-1970: results of treatment and major complications. I. Lymphedema.

Authors:  P W Martimbeau; K E Kjorstad; P Kolstad
Journal:  Am J Obstet Gynecol       Date:  1978-06-15       Impact factor: 8.661

9.  Postoperative radiotherapy in carcinoma of the cervix: treatment results and prognostic factors.

Authors:  G Atkovar; M Ozşahin; S Koca; I Sahinler; S Okkan; R Uzel
Journal:  Radiother Oncol       Date:  1995-06       Impact factor: 6.280

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  11 in total

1.  Survival and prognosticators of node-positive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.

Authors:  Masayoshi Hosaka; Hidemichi Watari; Takashi Mitamura; Yousuke Konno; Tetsuji Odagiri; Tatsuya Kato; Mahito Takeda; Noriaki Sakuragi
Journal:  Int J Clin Oncol       Date:  2010-09-15       Impact factor: 3.402

Review 2.  The impact of radiation on lymphedema: a review of the literature.

Authors:  Omar Allam; Kitae E Park; Ludmila Chandler; Mohammad Ali Mozaffari; Maham Ahmad; Xiaona Lu; Michael Alperovich
Journal:  Gland Surg       Date:  2020-04

3.  Risk factors for lower-limb lymphedema after surgery for cervical cancer.

Authors:  Yoko Ohba; Yukiharu Todo; Noriko Kobayashi; Masanori Kaneuchi; Hidemichi Watari; Mahito Takeda; Satoko Sudo; Masataka Kudo; Hidenori Kato; Noriaki Sakuragi
Journal:  Int J Clin Oncol       Date:  2011-01-07       Impact factor: 3.402

4.  Helical tomotherapy in cervical cancer patients: simultaneous integrated boost concept: technique and acute toxicity.

Authors:  Simone Marnitz; Carmen Stromberger; Michael Kawgan-Kagan; Waldemar Wlodarczyk; Ulrich Jahn; Achim Schneider; Uwe Ulrich; Volker Budach; Christhardt Köhler
Journal:  Strahlenther Onkol       Date:  2010-09-30       Impact factor: 3.621

Review 5.  Postoperative radiation therapy for carcinoma of the uterine cervix.

Authors:  Takashi Uno; Koichi Isobe; Seiji Yamamoto; Tetsuya Kawata; Hisao Ito
Journal:  Radiat Med       Date:  2006-02

Review 6.  Recent progress in the treatment and prevention of cancer-related lymphedema.

Authors:  Simona F Shaitelman; Kate D Cromwell; John C Rasmussen; Nicole L Stout; Jane M Armer; Bonnie B Lasinski; Janice N Cormier
Journal:  CA Cancer J Clin       Date:  2014-11-19       Impact factor: 508.702

7.  An experimental lymphoscintigraphy study in an acute unilateral deep venous thrombosis model.

Authors:  Zehra Pınar Koç; Oktay Burma; Ayhan Uysal; Hüseyin Aydın Mitil
Journal:  Lymphat Res Biol       Date:  2013-06       Impact factor: 2.589

8.  Procedural Recommendations for Lymphoscintigraphy in the Diagnosis of Peripheral Lymphedema: the Genoa Protocol.

Authors:  G Villa; C C Campisi; M Ryan; F Boccardo; P Di Summa; M Frascio; G Sambuceti; C Campisi
Journal:  Nucl Med Mol Imaging       Date:  2019-01-07

9.  Lymphedema following cancer therapy in Slovenia: a frequently overlooked condition?

Authors:  Tanja Planinsek Rucigaj; Nada Kecelj Leskovec; Vesna Tlaker Zunter
Journal:  Radiol Oncol       Date:  2010-11-16       Impact factor: 2.991

10.  Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma.

Authors:  Harue Tada; Satoshi Teramukai; Masanori Fukushima; Hiroshi Sasaki
Journal:  BMC Cancer       Date:  2009-02-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.